Suchergebnisse - "Drug Repositioning"

PubPharm (2.018)

81

Drug Repositioning of Inflammatory Bowel Disease Based on Co-Target Gene Expression Signature of Glucocorticoid Receptor and TET2

in: Biology | 2024

von Xianglin Zhao | Chenghao Hu | Xinyu Chen | +2

82

Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of α-synuclein propagation: Implications in Parkinson’s disease

in: Biomedicine & Pharmacotherapy | 2024

von Jae-Bong Kim | Soo-Jeong Kim | Minyoung So | +9

83

Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination

in: Vaccines | 2024

von Brittany A. Comunale | Robin J. Larson | Yea-Jen Hsu | +4

84

Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation

in: Molecules | 2024

von Muhammad Yasir | Jinyoung Park | Eun-Taek Han | +3

85

Repositioning of the Antihyperlipidemic Drug Fenofibrate for the Management of

in: Microorganisms | 2024

von Roberto M. Guerra | Maria José Figueras | Isabel Pujol-Bajador | +1

86

Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat

in: Genes | 2024

von Bruno Hay Mele | Federica Rossetti | Maria Vittoria Cubellis | +2

87

Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines

in: Biomedicines | 2024

von Nanami Irie | Kana Mizoguchi | Tomoko Warita | +7

88

The exoprotein Gbp of Fusobacterium nucleatum promotes THP-1 cell lipid deposition by binding to CypA and activating PI3K-AKT/MAPK/NF-κB pathways

in: Journal of Advanced Research | 2024

von Song Shen | Tianyong Sun | Xiangjiu Ding | +7

89

Phospholipid metabolic adaptation promotes survival of IDH2 mutant acute myeloid leukemia cells

enthalten in: Cancer science | 2024

von Morishima, T. | Takahashi, K. | Chin, D. | +6

90

Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist

enthalten in: Chemical & pharmaceutical bulletin | 2024

von Okada, M. | Nose, T.